| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.19 | 3e-05 |
| mRNA | VX-680 | GDSC1000 | pan-cancer | AAC | 0.22 | 3e-05 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | 0.13 | 6e-05 |
| mRNA | MLN2480 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-05 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 7e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.11 | 9e-05 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.17 | 9e-05 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |